Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. (2017)
Attributed to:
MICA: Neurokinin 3 Receptor Antagonism as a Novel Treatment for Menopausal Hot Flushes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(17)30823-1
PubMed Identifier: 28385352
Publication URI: http://europepmc.org/abstract/MED/28385352
Type: Journal Article/Review
Volume: 389
Parent Publication: Lancet (London, England)
Issue: 10081
ISSN: 0140-6736